Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

624
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
624
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.7K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.7K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

1.7K
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
1.7K
Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An interpretable, clinically-aligned AI paradigm for VTE risk prediction: an approach using LLMs and compound attention.

Computer methods in biomechanics and biomedical engineering·2026
Same author

Organoid modeling of lung branching morphogenesis and epithelial lineage specification.

Developmental cell·2026
Same author

MeDiCNet: Integrating Multi-scale Dynamic Convolution and Enhanced Position-Aware Transformer for DNA Methylation Site Prediction.

Interdisciplinary sciences, computational life sciences·2026
Same author

AviTag-seq unifies nucleotide-resolution maps of CRISPR off-targets and AAV vector integrations.

Communications biology·2026
Same author

Processing unstructured clinical notes with LLMs: applying the CMQOE framework for hypertension.

Medical & biological engineering & computing·2026
Same author

Asymmetric division in a two-cell-like state rejuvenates embryonic stem cells.

Cell research·2026
Same journal

Corrigendum to "Discovery of Benfotiamine as a subnanomolar P2Y<sub>14</sub>R antagonist for inflammatory diseases via drug repurposing and molecular dynamics-guided mechanism elucidation" [Eur. J. Med. Chem. 316 (2026) 119068].

European journal of medicinal chemistry·2026
Same journal

Identification of 3-arylquinoxalin-2(1H)-one derivatives targeting BRD4 BD1 as efficient anticancer agents.

European journal of medicinal chemistry·2026
Same journal

Discovery of novel ROCK inhibitors RX-021 and RX-044 with intraocular pressure-lowering effect for glaucoma treatment.

European journal of medicinal chemistry·2026
Same journal

Discovery of a novel benzoselenophene derivative as a potential therapeutic agent for pulmonary fibrosis.

European journal of medicinal chemistry·2026
Same journal

Design, synthesis and evaluation of dual modulators targeting glutaminyl cyclase and cannabinoid CB2 receptor.

European journal of medicinal chemistry·2026
Same journal

Discovery of N-(6-Acetylpyridin-3-yl)-2-(4-(ethylsulfonyl)phenyl)acetamide derivatives as a novel series of selective RORγt antagonists.

European journal of medicinal chemistry·2026
查看所有相关文章

相关实验视频

Updated: Jan 18, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K

HPDAF:使用多式联络特征预测药物标结合亲和力的实用工具.

An Gong1, Bing Yu1, Lekai Zhang1

  • 1Qingdao Institute of Software, College of Computer Science and Technology, China University of Petroleum (East China), Qingdao, 266580, China; Shandong Key Laboratory of Intelligent Oil & Gas Industrial Software, Qingdao, 266580, China.

European journal of medicinal chemistry
|September 11, 2025
PubMed
概括
此摘要是机器生成的。

HPDAF是一种新的多式联络深度学习工具,通过整合蛋白序列,药物分子图形和结合口袋结构,准确地预测药物标结合亲和力. 这种方法提高了药物发现和虚拟查效率的药物化学家.

关键词:
深度学习是一种深度学习.药物发现 药物发现药物标结合亲和力 药物标结合亲和力层次化的注意力.多式联络特征融合多式联络特征融合结构性解释性 结构性解释性

更多相关视频

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

相关实验视频

Last Updated: Jan 18, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K
Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

1.4K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K

科学领域:

  • 计算化学是一种计算化学.
  • 药物的发现和设计.
  • 生物信息学是一种生物信息学.

背景情况:

  • 准确预测药物标结合亲和力对于有效的药物发现至关重要.
  • 当前的计算方法很难有效地整合各种分子特征.
  • 需要先进的工具来提高结合亲和力预测的准确性.

研究的目的:

  • 引入HPDAF,这是一个多式联络深度学习工具,用于增强药物标结合亲和力预测.
  • 开发一种有效整合蛋白质序列,药物分子图表和结合口袋结构数据的方法.
  • 提高计算药物发现工具的准确性和实用性.

主要方法:

  • 惠普DAF采用多式联机深度学习方法.
  • 它整合了蛋白质序列,药物分子图和蛋白质结合口袋结构数据.
  • 一个分层的注意力机制将这些特征结合起来,以动态强调相关信息.

主要成果:

  • 在基准数据集 (CASF-2016,CASF-2013) 上,HPDAF表现出卓越的预测性能.
  • 该模型有效地整合了各种生物化学信息,以提高准确性.
  • 与最先进的方法相比,观察到始终优越的性能.

结论:

  • HPDAF为药物标结合亲和力预测提供了更高的准确性.
  • 该工具的实用性使药物化学家在药物设计和虚拟查方面受益.
  • 在计算药物发现方面,HPDAF代表了一项宝贵的进步.